SequelSEC

BeyondSpring Inc. BYSI

Pharmaceutical Preparations · CIK 0001677940 · Fiscal year ends 1231

Revenue
$0
Fiscal year ended 2026-06-30
Operating income
-$8.35M
Fiscal year ended 2026-06-30
Free cash flow
-$16.75M
Fiscal year ended 2026-06-30

BeyondSpring Inc. (BYSI) reported revenue of $0 and net income of -$6.68M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from BeyondSpring Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

BeyondSpring Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$0
Cost of revenueUnavailable
Gross profitUnavailable
Operating income-$8.35M
Net income-$6.68M
Research & development$4.56M
Weighted-average diluted sharesUnavailable
Pretax income-$8.01M
Income tax expense$340.00K
Diluted EPSUnavailable
Selling, general & administrative$3.79M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

BeyondSpring Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$2.70M
Total assets$14.61M
Current assets$9.90M
Total liabilities$50.63M
Current liabilities$14.19M
Total equity incl. NCI-$36.02M
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivableUnavailable
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$790.00K

Cash flow

BeyondSpring Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$16.75M
Capital expenditures$0
Investing cash flow-$1.89M
Financing cash flow$737.00K
Net change in cash-$17.76M
Stock-based compensation$1.37M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

BeyondSpring Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow-$16.75M
Gross marginUnavailable
Operating marginUnavailable
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio0.70x
Revenue YoY growthUnavailable
Net marginUnavailable
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BYSI in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-13View SEC filing
10-K · Filed 2026-03-25View SEC filing
10-Q · Filed 2025-11-12View SEC filing
10-Q · Filed 2025-08-13View SEC filing
10-Q · Filed 2025-05-12View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.